Please assess the completion status of the following clinical trial:

Trial Title: Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with overt GI bleeding (hematemesis, coffee-grounds, rectal bleeding and/or melena) with negative OGD but not critically ill, who should read positive on small bowel investigation (SBI)~2. Patients with occult GI bleeding (Faecal occult blood test,FOBT +)~3. Patients with suspected arteriovenous(AV) malformations.~4. Patients treated with nonsteroidal antiinflammatory drugs (NSAIDs)~5. Patients with active Crohn's disease(CD), with no evidence of obstruction~Exclusion Criteria:~1. In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-ingestion testing and profile.~2. In patients with cardiac pacemakers or other implanted electromedical devices.~3. In patients with dysphagia or other swallowing disorders.~4. Unable to obtain informed written consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Colon 2 (Type: EXPERIMENTAL): using Colon 2 capsule in detecting bleeding events in small bowel

Based on this trial design, predict the completion outcome and termination type (if applicable).